These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25636172)

  • 41. Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.
    Copie-Bergman C; Gaulard P; Leroy K; Briere J; Baia M; Jais JP; Salles GA; Berger F; Haioun C; Tilly H; Emile JF; Banham AH; Mounier N; Gisselbrecht C; Feugier P; Coiffier B; Molina TJ
    J Clin Oncol; 2009 Nov; 27(33):5573-9. PubMed ID: 19786664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical characteristics, cell origin and prognosis of primary gastrointestinal diffuse large B-cell lymphoma: a report of 40 cases].
    Yang YL; Wang J; Zhao LZ; Gao ZF; Jing HM; Ke XY
    Ai Zheng; 2008 Jun; 27(6):636-41. PubMed ID: 18570740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.
    Montagut C; Tusquets I; Ferrer B; Corominas JM; Bellosillo B; Campas C; Suarez M; Fabregat X; Campo E; Gascon P; Serrano S; Fernandez PL; Rovira A; Albanell J
    Endocr Relat Cancer; 2006 Jun; 13(2):607-16. PubMed ID: 16728586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma.
    Espinosa I; Briones J; Bordes R; Brunet S; Martino R; Sureda A; Prat J; Sierra J
    Ann Hematol; 2006 Sep; 85(9):597-603. PubMed ID: 16830142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. β-TrCP1 promotes cell proliferation via TNF-dependent NF-κB activation in diffuse large B cell lymphoma.
    Cai N; Chen Z; Huang Y; Shao S; Yu H; Wang Y; He S
    Cancer Biol Ther; 2020; 21(3):241-247. PubMed ID: 31731887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein kinase C-associated kinase is required for NF-kappaB signaling and survival in diffuse large B-cell lymphoma cells.
    Kim SW; Oleksyn DW; Rossi RM; Jordan CT; Sanz I; Chen L; Zhao J
    Blood; 2008 Feb; 111(3):1644-53. PubMed ID: 18025152
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Co-expression of NF-κB-p65 and phosphorylated NF-κB-p105 is associated with poor prognosis in surgically resectable non-small cell lung cancer.
    Lin G; Li C; Huang C; Zhuang W; Huang Y; Xu H; Miao Q; Hu D
    J Cell Mol Med; 2018 Mar; 22(3):1923-1930. PubMed ID: 29363879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type.
    Pham-Ledard A; Beylot-Barry M; Barbe C; Leduc M; Petrella T; Vergier B; Martinez F; Cappellen D; Merlio JP; Grange F
    JAMA Dermatol; 2014 Nov; 150(11):1173-9. PubMed ID: 25055137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NF-κB p65 represses microRNA-124 transcription in diffuse large B-cell lymphoma.
    Shim H; Nam J; Kim SW
    Genes Genomics; 2020 May; 42(5):543-551. PubMed ID: 32207045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma.
    Eluard B; Nuan-Aliman S; Faumont N; Collares D; Bordereaux D; Montagne A; Martins I; Cagnard N; Caly M; Taoui O; Lordello L; Lehmann-Che J; Tesson B; Martinez-Climent JA; Copie-Bergman C; Haioun C; Tilly H; Bonsang B; Vincent-Salomon A; Jais JP; Jardin F; Leroy K; Maiuri MC; Kroemer G; Molina TJ; Feuillard J; Baud V
    Blood; 2022 Jan; 139(3):384-398. PubMed ID: 34232979
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prognostic value of Skp2 expression in Egyptian diffuse large B-cell lymphoma.
    Abdou AG; Asaad NY; Abd El-Wahed MM; Samaka RM; Allah MS
    Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):47-55. PubMed ID: 21558842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL).
    Mudaliar MA; Haggart RD; Miele G; Sellar G; Tan KA; Goodlad JR; Milne E; Vail DM; Kurzman I; Crowther D; Argyle DJ
    PLoS One; 2013; 8(9):e72591. PubMed ID: 24023754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of P2X7 receptor activation on nuclear factor-κB phosphorylation induced by status epilepticus in the rat hippocampus.
    Kim JE; Kim DS; Jin Ryu H; Il Kim W; Kim MJ; Won Kim D; Young Choi S; Kang TC
    Hippocampus; 2013 Jun; 23(6):500-14. PubMed ID: 23564500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fc receptor-like 1 (FCRL1) is a novel biomarker for prognosis and a possible therapeutic target in diffuse large B-cell lymphoma.
    Yousefi Z; Sharifzadeh S; Zare F; Eskandari N
    Mol Biol Rep; 2023 Feb; 50(2):1133-1145. PubMed ID: 36409389
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.
    Arcaini L; Rossi D; Lucioni M; Nicola M; Bruscaggin A; Fiaccadori V; Riboni R; Ramponi A; Ferretti VV; Cresta S; Casaluci GM; Bonfichi M; Gotti M; Merli M; Maffi A; Arra M; Varettoni M; Rattotti S; Morello L; Guerrera ML; Sciarra R; Gaidano G; Cazzola M; Paulli M
    Haematologica; 2015 Feb; 100(2):246-52. PubMed ID: 25381127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA signature is indicative of long term prognosis in diffuse large B-cell lymphoma.
    Shepshelovich D; Ram R; Uziel O; Kushnir M; Lithwick-Yanai G; Hoshen M; Feinmesser M; Bairey O; Lahav M
    Leuk Res; 2015 Jun; 39(6):632-7. PubMed ID: 25866097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicopathological correlations of the immunoprofile in diffuse large B-cell lymphoma NOS - a single institutions experience.
    Flodr P; Látalová P; Tichý M; Kubová Z; Papajík T; Šváchová M; Radová L; Jarošová M
    Cesk Patol; 2016; 52(1):47-54. PubMed ID: 27108556
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer.
    Puvvada SD; Funkhouser WK; Greene K; Deal A; Chu H; Baldwin AS; Tepper JE; O'Neil BH
    Oncology; 2010; 78(3-4):181-8. PubMed ID: 20414006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic drivers of NF-κB deregulation in diffuse large B-cell lymphoma.
    Pasqualucci L; Zhang B
    Semin Cancer Biol; 2016 Aug; 39():26-31. PubMed ID: 27546290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma.
    Mareschal S; Dubois S; Viailly PJ; Bertrand P; Bohers E; Maingonnat C; Jaïs JP; Tesson B; Ruminy P; Peyrouze P; Copie-Bergman C; Fest T; Jo Molina T; Haioun C; Salles G; Tilly H; Lecroq T; Leroy K; Jardin F
    Genes Chromosomes Cancer; 2016 Mar; 55(3):251-67. PubMed ID: 26608593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.